The door has closed on guideline.gov, which provided physicians and others with information on best medical practices, but ECRI Institute said it will maintain a version of the resource.
Foundation Medicine and ThermoFisher Scientific are big beneficiaries of CMS widening its coverage and making a national coverage decision for next-generation sequencing of metastatic, Stage 3 or 4 and other cancers.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.